-
Report details
-
17
Figures
-
7
Tables
-
Market Analysis: Molecular Infectious Disease
-
Overview of Molecular Testing for Infectious Diseases
-
Market Outlook
-
Major Product Activity
-
Immunoassay Vs. Molecular Testing Techniques
-
Regional Market
-
Top Company Briefs
-
Executive News Briefing
-
BioMark Diagnostics Increased Funding
-
Sense Biodetection Raises Additional Funds
-
Inflammatix Receives Additional Funding
-
Selux Diagnostics Welcomes John Wilson
-
3Q 2021 Highlights: Bio-Rad, Illumina and PerkinElmer
-
Clinical Diagnostic Sales Drive Bio-Rad Laboratories’ Sales in Q3 2021
-
Illumina Reports “Revenue of $1,108 million, a 40% increase compared to the prio…
-
PerkinElmer reports 25% Growth in Q3 2021 for Non-COVID Diagnostics
-
Diagnostic Market Mergers, Acquisitions and Partnership Deals
-
Mergers and Acquisitions
-
Partnerships and Collaborations
-
Industry Watch
-
Region Watch
-
Broad-based Company Announcements
-
BioCartis
-
Prenosis
-
Aiforia
-
LifeCell
-
DiaSorin and MeMed
-
NGeneBio
-
Genedrive
|
In Vitro Diagnostics Business Outlook: Volume 1, Issue 4 - Molecular Infectious Disease
7 Dec 2021
Team Price (5 users, 1 year)
A new twice-monthly publication dedicated to IVD, In Vitro Diagnostics Business Outlook offers the following:
• Market Sizing and Forecasting of IVD Market Segments in Every Issue
• Clinical Chemistry, Infectious Disease Testing, Oncology, Hematology, Blood Banking, Coagulation, Point of Care–Updates on the Important Test Categories You Need to Know About
• Industry Watch – Developments with COVID-19 and Other Testing
• M&A, Distribution, Partnerships Tracked and Charted
• New Product Introductions and Company Announcements
• Company Profiling and Quarterly Results Summaries
• Regional Market Coverage
Page Count: 43
Table of Contents
-
Market Analysis: Molecular Infectious Disease
-
Overview of Molecular Testing for Infectious Diseases
-
Market Outlook
-
Major Product Activity
-
Immunoassay Vs. Molecular Testing Techniques
-
Regional Market
-
Top Company Briefs
-
Executive News Briefing
-
BioMark Diagnostics Increased Funding
-
Sense Biodetection Raises Additional Funds
-
Inflammatix Receives Additional Funding
-
Selux Diagnostics Welcomes John Wilson
-
3Q 2021 Highlights: Bio-Rad, Illumina and PerkinElmer
-
Clinical Diagnostic Sales Drive Bio-Rad Laboratories’ Sales in Q3 2021
-
Illumina Reports “Revenue of $1,108 million, a 40% increase compared to the prior year period”
-
PerkinElmer reports 25% Growth in Q3 2021 for Non-COVID Diagnostics
-
Diagnostic Market Mergers, Acquisitions and Partnership Deals
-
Mergers and Acquisitions
-
Partnerships and Collaborations
-
Industry Watch
-
Region Watch
-
Broad-based Company Announcements
-
BioCartis
-
Prenosis
-
Aiforia
-
LifeCell
-
DiaSorin and MeMed
-
NGeneBio
-
Genedrive
|
More information about this product
Other Users Also Viewed
25 Aug 2021
21-050
Kalorama Information’s latest edition of our in vitro diagnostic market report represents the fourteenth time in two decades our analysts have fully assessed the in vitro diagnostic market from scratch and re-report numbers. Last year,…
|